Product Information
METOPROLOL SUCC ER 200 MG TAB is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.1859 per EA under NDC 75834029301. Its NADAC has been published 217 times since Jun 1, 2022.
FDA first approved this application on Mar 30, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834029301
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
METOPROLOL SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA203699FDA Approved
3/30/2020
TE Code
AB
On Market Since
2/26/2021
Pharmacological Classes
Price Statistics
The NADAC for METOPROLOL SUCC ER 200 MG TAB has been published 217 times since Jun 1, 2022, and over the history we have for it it has declined 13.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1859 per EA |
|---|---|
| All-time high | $0.2917 (Oct 12, 2022) |
| All-time low | $0.1284 (Nov 20, 2024) |
| 52-week high | $0.1997 |
| 52-week low | $0.1588 |
| Median price | $0.1853 |
| Average price | $0.1932 |
| Largest weekly change | +48.9% (Aug 23, 2023) |
| Weeks tracked | 217 |
| Tracking since | Jun 1, 2022 |
1W
N/A
1M
N/A
3M
+7.2%
6M
+2.1%
1Y
+6.7%
3Y
+8.4%
5Y
N/A
All
-13.4%
Last surveyed Jul 22, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METOPROLOL SUCC ER 200 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL SUCC ER 200 MG TAB, manufactured by Nivagen Pharmaceuticals Inc., is $0.1859 per EA (NDC 75834029301), effective Jul 22, 2026.
How has the price of METOPROLOL SUCC ER 200 MG TAB changed over time?
Over the history we have for it, the NADAC for METOPROLOL SUCC ER 200 MG TAB has declined 13.4%. It has been tracked across 217 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for METOPROLOL SUCC ER 200 MG TAB?
Since Jun 1, 2022, the NADAC for METOPROLOL SUCC ER 200 MG TAB has ranged from a low of $0.1284 (Nov 20, 2024) to a high of $0.2917 (Oct 12, 2022), with a median of $0.1853 per EA.
Are there cheaper alternatives to METOPROLOL SUCC ER 200 MG TAB?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METOPROLOL SUCC ER 200 MG TAB, is $0.1678 per EA — about 10% below METOPROLOL SUCC ER 200 MG TAB.
Who manufactures METOPROLOL SUCC ER 200 MG TAB?
METOPROLOL SUCC ER 200 MG TAB (NDC 75834029301) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.